Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatichanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier function. GUCY2C may represent a new target for anti-obesity pharmacotherapy.
95 % as determined by Tris-Bis PAGE, 95 % as determined by HPLC.
Target:
Cynomolgus GUCY2C/Guanylyl cyclase C
Application Notes:
Cross-Reactivity: Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage,it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA,5% HSA,10% FBS or 5% Trehalose),and aliquot the reconstituted protein solution to minimize free-thaw cycles. ResearchArea: Other Recombinant Protein
* VAT and and shipping costs not included. Errors and price changes excepted
